🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Pancreatic Head Cancer

Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers NCT02584244Phase 1, Phase 21 site📍 Boston Lumicell, Inc. · Tests: LUM015, LUM 2.6 Imaging Device An International Study on Pediatric Patients With Rare Tumors. NCT07072143n/a1 site📍 Padova Azienda Ospedaliera di Padova A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors NCT05208762Phase 162 sites📍 Birmingham📍 Birmingham📍 Birmingham Seagen, a wholly owned subsidiary of Pfizer · Tests: PF-08046054, pembrolizumab Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA) NCT07262957Phase 41 site📍 Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: HOP bundle Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors NCT07360314Phase 19 sites📍 New Haven📍 Huntersville📍 Galveston EMD Serono Research & Development Institute, Inc. · Tests: M7437, M7437 AI-Assisted Non-Contrast CT for Multi-Cancer Screening NCT06632886NA1 site📍 Shanghai Guo ShiWei · Tests: AI-Assisted Non-Contrast CT for Multi-Cancer Screening 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors NCT07557225NA1 site📍 Beijing Peking University First Hospital · Tests: 18F-T2 PET/CT Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas NCT07155525NA1 site📍 Minya Minia University · Tests: Pancreaticojejunostomy with Modified N-Butyl-2-Cyanoacrylate (Glubran® 2), Standard(duct-to-mucosa) Pancreaticojejunost… Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques NCT07035587n/a1 site📍 Seoul Yonsei University · Tests: Serial Blood Sampling for Molecular Profiling, One-Time Blood Sampling for Molecular Profiling Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors NCT05969041Phase 16 sites📍 Darlinghurst📍 Randwick📍 Westmead Myeloid Therapeutics · Tests: MT-302 (A) Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow NCT03551951n/a1 site📍 Columbia University of Missouri-Columbia · Tests: Test for circulating tumor cells, DNA alterations A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors NCT07277413Phase 123 sites📍 Goodyear📍 Phoenix📍 Duarte IDEAYA Biosciences · Tests: IDE892, IDE397 A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors NCT04895709Phase 1, Phase 247 sites📍 Clovis📍 Los Angeles📍 Newport Beach Bristol-Myers Squibb · Tests: BMS-986340, BMS-936558-01, Docetaxel, Pumitamig IDOV-Immune for Advanced Solid Tumors NCT06910657Phase 15 sites📍 St Louis📍 Houston📍 San Antonio ViroMissile, Inc. · Tests: IDOV-Immune (oncolytic vaccinia virus) A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation NCT06778863Phase 121 sites📍 Scottsdale📍 Tucson📍 Los Angeles Clasp Therapeutics, Inc. · Tests: CLSP-1025 LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology NCT05184790n/a4 sites📍 Saint Leonards📍 Woolloongabba📍 Melbourne University of Sydney BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion NCT07594626Phase 1, Phase 21 site📍 Chicago Northwestern University · Tests: Biospecimen Collection, Computed Tomography, Pemetrexed, PRMT5 Inhibitor BMS-986504 Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors NCT05985655Phase 1, Phase 215 sites📍 Los Angeles📍 Grand Rapids📍 New York Exscientia AI Ltd., a wholly owned subsidiary of Recursion … · Tests: GTAEXS617, SoC Resilience and Equity in Aging, Cancer, and Health (REACH) NCT04674267NA1 site📍 Boston Dana-Farber Cancer Institute · Tests: Phase 2 Intervention - Geriatric Co-Management Cancer Loyalty Card Study 2 (CLOCS-2) NCT06447064n/a1 site📍 London Imperial College London · Tests: Cases & Controls A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid Tumors NCT06500052Phase 11 site📍 Guangzhou Sichuan Baili Pharmaceutical Co., Ltd. · Tests: BL-M17D1 Breath Research Narrow Validation for Gastrointestinal Cancer Detection NCT07714538n/a6 sites📍 Maidstone📍 Liverpool📍 Glasgow Imperial College London PET-imaging of Two Vartumabs in Patients With Solid Tumors NCT06645808EARLY Phase 11 site📍 Groningen Var2 Pharmaceuticals · Tests: 89Zr-DFO-N-Suc-F8scFv, 89Zr-DFO-N-Suc-C9scFv, PET/CT scan A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors NCT07229313Phase 17 sites📍 Santa Monica📍 New Have📍 Camperdown Kivu Bioscience Inc. · Tests: KIVU-107 Brodalumab in the Treatment of Immune-Related Adverse Events NCT06673329Phase 11 site📍 New York Brian Henick, MD · Tests: Brodalumab, CT scan Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) NCT04498767NA13 sites📍 Anderlecht📍 Ghent📍 Wilrijk European Organisation for Research and Treatment of Cancer … · Tests: Stereotactic body radiotherapy, Palliative RT A Study of Multiparametric Ultrasound Imaging Methods NCT07270237NA7 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Multiparametric ultrasound (mpUS) imaging Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study NCT06534762Phase 21 site📍 Hangzhou Zhejiang Provincial People's Hospital · Tests: Mirabegron 18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis NCT06937112n/a1 site📍 Nanjing Nanjing First Hospital, Nanjing Medical University · Tests: PET-CT examination Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer Patients NCT05850130NA15 sites📍 Amiens📍 Caen📍 Créteil GERCOR - Multidisciplinary Oncology Cooperative Group · Tests: Acupuncture intervention, No acupuncture
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy